HACE1 and gastric cancer: Our previous study revealed that HACE1 was pravelently downregulated in gastric cancer, and its reduced protein level related to a poor prognosis, so we are interested to know whether HACE1 regualtes cisplatin resistance, thereby, affecting the prognosis.15